Identification and in silico characterization of a novel peptide inhibitor of angiotensin converting enzyme from pigeon pea (Cajanus cajan)

Phytomedicine

Volumn 36, Issue , 2017, Pages 1-7

  Nawaz, K A Ayub ^a   David, Swapna Merlin ^a   Murugesh, Easwaran ^a   Thandeeswaran, Murugesan ^a   Kiran, Kalarikkal Gopikrishnan ^a   Mahendran, Ramasamy ^a   Palaniswamy, Muthusamy ^b   Angayarkanni, Jayaraman ^a  

^a BHARATHIAR UNIVERSITY   (India)

^b KARPAGAM UNIVERSITY   (India)

Author keywords

Angiotensin converting enzyme; Inhibitor; Molecular docking; Peptide; Purification

Indexed keywords

CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; OCTAPEPTIDE; ACE PROTEIN, HUMAN; DIPEPTIDYL CARBOXYPEPTIDASE; PEPTIDE;

AMINO ACID SEQUENCE; ARTICLE; ASPERGILLUS NIGER; BIOLOGICAL ACTIVITY; COMPUTER MODEL; CONTROLLED STUDY; DRUG IDENTIFICATION; HYPERTENSION; LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY; MOLECULAR DOCKING; MOLECULAR DYNAMICS; MOLECULAR WEIGHT; NONHUMAN; PIGEONPEA; PRIORITY JOURNAL; PROTEIN CONTENT; SIZE EXCLUSION CHROMATOGRAPHY; SOLID STATE FERMENTATION; CAJANUS; CHEMISTRY; COMPUTER SIMULATION; ENZYME ACTIVE SITE; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; PRECLINICAL STUDY; PROCEDURES; TANDEM MASS SPECTROMETRY;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ASPERGILLUS NIGER; CAJANUS; CATALYTIC DOMAIN; CHROMATOGRAPHY, GEL; COMPUTER SIMULATION; DRUG EVALUATION, PRECLINICAL; HUMANS; MOLECULAR DOCKING SIMULATION; MOLECULAR WEIGHT; PEPTIDES; PEPTIDYL-DIPEPTIDASE A; TANDEM MASS SPECTROMETRY;

EID: 85030865375     PISSN: 09447113     EISSN: 1618095X     Source Type: Journal    
DOI: 10.1016/j.phymed.2017.09.013     Document Type: Article

References (30)

1. Aluko, R.E., Determination of nutritional and bioactive properties of peptides inenzymatic pea, chickpea, and mung bean protein hydrolysates. J. AOAC. Int. 91 (2008), 947–956.
2. Bhuyan, B.J., Mugesh, G., Angiotensin converting enzyme inhibitors in the treatment of hypertension. Curr. Sci. India. 101 (2011), 881–887.
3. Chaudhary, S., Vats, I.D., Chopra, M., Biswas, P., Pasha, S., Effect of varying chain length between P-1 and P-1′ position of tripeptidomimics on activity of angiotensin-converting enzyme inhibitors. Bioorg. Med. Chem. Lett. 19 (2009), 4364–4366.
4. Chel-Guerrero, L., Domínguez-Magaña, M., Martínez-Ayala, A., Dávila-Ortiz, G., Betancur-Ancona, D., Lima bean (Phaseolus lunatus) protein hydrolysates with ACE-I inhibitory activity. Food Nutr. Sci. 3 (2012), 511–521.
5. Cheung, H.S., Cushman, D.W., Inhibition of homogeneous Angiotensin I converting enzyme of rabbit lung by synthetic venom peptides of Bothrops Jararaca. Biochim. Biophys. Acta. 293 (1973), 451–463.
6. Cheung, H.S., Wang, F.L., Ondetti, M.A., Sabo, E.F., Cushman, D.W., Binding of peptide substrates and inhibitors of angiotensin-converting enzyme: importance of the COOH-terminal dipeptide sequence. J. Biol. Chem. 255 (1980), 401–407.
7. Cushman, D.W., Cheung, H.S., Spectrophotometric assay and properties of the angiotensin converting enzyme of rabbit lung. Biochem. Pharmacol. 20 (1971), 1637–1648.
8. Danquah, M.K., Agyei, D., Pharmaceutical applications of bioactive peptides. OA. Biotechnol. 1 (2012), 5–11.
9. Erdos, E.G., The ACE and I: how ACE inhibitors came to be. FASEB. J. 20 (2006), 1034–1038.
10. FitzGerald, R.J., Murray, B.A., Walsh, D.J., Hypotensive peptides from milk proteins. J. Nutr. 134 (2004), 980S–988S.
11. Flint, L., The role of ACE inhibitor therapy in treating cardiovascular disease. Nurs. Times. 100 (2004), 34–36.
12. Gibbs, B.F., Zougman, A., Masse, R., Mulligan, C., Production and characterization of bioactive peptides from soy hydrolysate and soy-fermented. Food Res. Int. 37 (2004), 123–131.
13. Gobbetti, M., Ferranti, P., Smacchi, E., Goffredi, F., Addeo, F., Production of angiotensin-I-converting enzyme inhibitory peptides in fermented milks started by Lactobacillus delbrueckii subsp. bulgaricus SS1 and Lactococcus lactis subsp. cremoris FT4. Appl. Environ. Microb. 66 (2000), 3898–3904.
14. Guang, C., Phillips, R.D., Plant food-derived angiotensin I converting enzyme inhibitory peptides. J. Agr. Food Chem. 57 (2009), 5113–5130.
15. Hong, F., Ming, L., Yi, S., Zhanxia, L., Yongquan, W., Chi, L., The antihypertensive effect of peptides: a novel alternative to drugs?. Peptides 29 (2008), 1062–1071.
16. Jang, J.H., Jeong, S.C., Kim, J.H., Lee, Y.H., Ju, Y.C., Lee, J.S., Characterisation of a new antihypertensive angiotensin I-converting enzyme inhibitory peptide from Pleurotus cornucopiae. Food Chem. 127 (2011), 412–418.
17. Kohama, Y., Oka, H., Yamamoto, K., Teramoto, T., Okabe, M., Mimura, T., Nagase, Y., Chiba, Y., Fujita, T., Induction of angiotensin-converting enzyme inhibitory activity by acid-limited proteolysis of glyceraldehyde 3-phosphate dehydrogenase. Biochem. Bioph. Res. Co. 161 (1989), 456–460.
18. Korhonen, H., Pihlanto, A., Bioactive peptides: production and functionality. Int. Dairy J. 16 (2006), 945–960.
19. Li, P., Jia, J., Fang, M., Zhang, L., Guo, M., Xie, J., In vitro and in vivo ACE inhibitory of pistachio hydrolysates and in silico mechanism of identified peptide binding with ACE. Process Biochem. 49 (2014), 898–904.
20. Lowry, O.H., Rosebrough, N.J., Farr, A.L., Randall, R.J., Protein measurement with folin phenol reagent. J. Biol. Chem. 193 (1951), 265–267.
21. Mahato, R.L., Narang, A.S., Thomas, L., Miller, D.D., Emerging trends in oral delivery of peptide and protein drugs. Crit. Rev. Ther. Drug. 20 (2003), 153–214.
22. Matsufuji, H., Matsui, T., Seki, E., Osajima, K., Nakashima, M., Osajima, Y., Angiotensin I-converting enzyme inhibitory peptides in an alkaline protease hydrolyzate derived from sardine muscle. Biosci. Biotech. Bioch. 58 (1994), 2244–2245.
23. Nakagomi, K., Yamada, R., Ebisu, H., Sadakane, Y., Akizawa, T., Tanimura, T., Isolation of acein-2, a novel angiotensin-I-converting enzyme inhibitory peptide derived from a tryptic hydrolysate if human plasma. FEBS Lett. 467 (2000), 235–238.
24. Natesh, R., Schwager, S.L.U., Sturrock, E.D., Acharya, K.R., Crystal structure of the human angiotensin-converting enzyme-lisinopril complex. Nature 421 (2003), 551–554.
25. Qiang, W., Qiu-Feng, C., Zhi-Peng, T., Le-Chang, S., Jian-Dong, S., Ling-Jing, Z., Guang Ming, L., Min-Jie, C., Purification and characterization of a novel angiotensin I-converting enzyme inhibitory peptide derived from abalone (Haliotis discus hannai Ino) gonads. Eur. Food Res. Technol. 240 (2015), 137–145.
26. Rohit, A.C., Sathisha, K., Aparna, H.S., A variant peptide of buffalo colostrum beta-lactoglobulin inhibits angiotensin I-converting enzyme activity. Eur. J. Med. Chem. 53 (2012), 211–219.
27. Roy, F., Boye, J.I., Simpson, B.K., Bioactive proteins and peptides in pulse crops:Pea, chickpea and lentil. Food Res. Int. 43 (2010), 432–442.
28. Tsai, J.S., Lin, T.C., Chen, J.L., Pan, B.S., The inhibitory effects of freshwater clam (Corbicula fluminea, Muller) muscle protein hydrolysates on angiotensin I converting enzyme. Process Biochem. 41 (2006), 2276–2281.
29. Yoshiji, H., Kuriyama, S., Fukui, H., Angiotensin-I –converting enzyme inhibitors may be an alternative anti-angiogenic strategy in the treatment of liver fibrosis and hepatocellular carcinoma. Possible role of vascular endothelial growth factor. Tumour Biol. 23 (2002), 348–356.
30. Zhang, J.H., Tatsumi, T., Ding, C.H., Li, L.T., Angiotensin I-converting enzyme inhibitory peptides in Douchi, a Chinese traditional fermented soybean product. Food Chem 98 (2006), 551–557.